{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T14:05:16Z","timestamp":1791641116740,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"METOXIA","award":["222741"],"award-info":[{"award-number":["222741"]}]},{"name":"NGI Pre-Seed","award":["93612005"],"award-info":[{"award-number":["93612005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.ejmech.2016.10.037","type":"journal-article","created":{"date-parts":[[2016,10,19]],"date-time":"2016-10-19T22:00:55Z","timestamp":1476914455000},"page":"691-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs"],"prefix":"10.1016","volume":"127","author":[{"given":"Simon J.A.","family":"van Kuijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda Kumar","family":"Parvathaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymon","family":"Niemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8318-7787","authenticated-orcid":false,"given":"Marike W.","family":"van Gisbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pastorekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala","family":"Yaromina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig J.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Winum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lambin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.10.037_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib2","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib3","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1021\/mp200292c","article-title":"Drug resistance and cellular adaptation to tumor acidic pH microenvironment","volume":"8","author":"Wojtkowiak","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2016.10.037_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.clon.2013.06.009","article-title":"The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology","volume":"25","author":"Good","year":"2013","journal-title":"Clin. Oncol. R. Coll. Radiol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.radonc.2015.08.022","article-title":"New ways to image and target tumour hypoxia and its molecular responses","volume":"116","author":"Dubois","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3109\/14756366.2014.966704","article-title":"Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium","volume":"30","author":"Pettersen","year":"2015","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"issue":"Suppl 1","key":"10.1016\/j.ejmech.2016.10.037_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756360902784425","article-title":"Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies","volume":"24","author":"Ebbesen","year":"2009","journal-title":"J.\u00a0Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib8","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3554","article-title":"Interfering with pH regulation in tumours as a therapeutic strategy","volume":"10","author":"Neri","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.10.037_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib10","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2016.10.037_bib11","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib12","first-page":"4469","article-title":"Lowered oxygen tension induces expression of the hypoxia marker MN\/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase","volume":"62","author":"Kaluz","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib13","doi-asserted-by":"crossref","first-page":"24204","DOI":"10.1074\/jbc.M109.006510","article-title":"Hypoxia-induced expression of carbonic anhydrase 9 is dependent on the unfolded protein response","volume":"284","author":"van den Beucken","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbaexp.2005.03.003","article-title":"MAPK pathway contributes to density- and hypoxia-induced expression of the tumor-associated carbonic anhydrase IX","volume":"1729","author":"Kopacek","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2016.10.037_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fonc.2016.00069","article-title":"Prognostic significance of carbonic anhydrase IX expression in Cancer patients: a meta-analysis","volume":"6","author":"van Kuijk","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11307-015-0831-y","article-title":"[(18)F]VM4-037 MicroPET imaging and biodistribution of two in\u00a0vivo caix-expressing tumor models","volume":"17","author":"Peeters","year":"2015","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2013.10.027","article-title":"Development and biological evaluation of (9)(9)mTc-sulfonamide derivatives for in\u00a0vivo visualization of CA IX as surrogate tumor hypoxia markers","volume":"71","author":"Akurathi","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.nucmedbio.2010.02.006","article-title":"Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in\u00a0vivo visualization of carbonic anhydrase IX expression in tumor hypoxia","volume":"37","author":"Akurathi","year":"2010","journal-title":"Nucl. Med. Biol."},{"issue":"13","key":"10.1016\/j.ejmech.2016.10.037_bib19","doi-asserted-by":"crossref","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","article-title":"Synthesis and in\u00a0vivo biological evaluation of 68Ga-Labeled carbonic anhydrase IX targeting small molecules for positron emission tomography","volume":"59","author":"Sneddon","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2016.10.037_bib21","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/jm300529u","article-title":"Antimetastatic effect of sulfamate carbonic anhydrase IX inhibitors in breast carcinoma xenografts","volume":"55","author":"Gieling","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib22","doi-asserted-by":"crossref","first-page":"24856","DOI":"10.18632\/oncotarget.4498","article-title":"Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in\u00a0vitro breast cancer models","volume":"6","author":"Ward","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2016.10.037_bib23","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2016.10.037_bib24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","article-title":"Specific inhibition of carbonic anhydrase IX activity enhances the in\u00a0vivo therapeutic effect of tumor irradiation","volume":"99","author":"Dubois","year":"2011","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib25","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase IX inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","author":"Rami","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2016.10.037_bib27","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2016.10.037_bib28","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.radonc.2013.06.018","article-title":"Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs","volume":"108","author":"Dubois","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib29","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1039\/C4TB02081B","article-title":"Coumarin\u2013benzothiazole\u2013chlorambucil (Cou\u2013Benz\u2013Cbl) conjugate: an ESIPT based pH sensitive photoresponsive drug delivery system","volume":"3","author":"Barman","year":"2015","journal-title":"J.\u00a0Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2016.10.037_bib30","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1021\/ja058077g","article-title":"Catalytic, enantioselective [4\u00a0+ 2]-cycloadditions of ketene enolates and o-quinones: efficient entry to chiral, alpha-oxygenated carboxylic acid derivatives","volume":"128","author":"Bekele","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.10.037_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0957-4166(00)86350-8","article-title":"Pigments of fungi, part 16. Synthesis of methyl (R)-(+)-tetrahydro-2-methyl-5-oxo-2-furanacetate and its (S)-(\u2212)-antipode, chiroptical references for determination of the absolute stereochemistry of fungal pre-anthraquinones","volume":"1","author":"Gill","year":"1990","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2016.10.037_bib32","series-title":"Process for Preparing Alkyl\/aryl Chloroformates, in, Google Patents","author":"Deshmukh","year":"2005"},{"key":"10.1016\/j.ejmech.2016.10.037_bib33","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1021\/jm800967h","article-title":"Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins","volume":"51","author":"Hay","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib34","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1021\/jm020936d","article-title":"Antitumor imidazotetrazines. 41. Conjugation of the antitumor agents mitozolomide and temozolomide to peptides and lexitropsins bearing DNA major and minor groove-binding structural motifs","volume":"45","author":"Arrowsmith","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/acsmedchemlett.5b00175","article-title":"Carbonic anhydrase glycoinhibitors belonging to the aminoxysulfonamide series","volume":"6","author":"Ombouma","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.10.037_bib36","first-page":"1100","article-title":"Synthesis of N-substituted 6-alkyl-2,4-diamino-1,3,5-triazines containing long alkyl radicals","volume":"24","author":"Kelarev","year":"1988","journal-title":"Zhurnal Organicheskoi Khimii"},{"key":"10.1016\/j.ejmech.2016.10.037_bib37","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with beta-catenin","volume":"290","author":"Svastova","year":"2003","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib38","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3109\/10428194.2014.963077","article-title":"Past, present and future role of chlorambucil in the treatment of chronic lymphocytic leukemia","volume":"56","author":"Goede","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejmech.2016.10.037_bib39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fonc.2016.00066","article-title":"Pathophysiological basis for the formation of the tumor microenvironment","volume":"6","author":"Horsman","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1517\/13543780802567250","article-title":"Tirapazamine: a novel agent targeting hypoxic tumor cells","volume":"18","author":"Reddy","year":"2009","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2016.10.037_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"Jama"},{"key":"10.1016\/j.ejmech.2016.10.037_bib42","first-page":"4845","article-title":"Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT","volume":"29","author":"Fukushima","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.radonc.2007.04.018","article-title":"Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors","volume":"83","author":"Dubois","year":"2007","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib44","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/0008-5472.CAN-11-2520","article-title":"Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors","volume":"71","author":"Ditte","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.radonc.2009.06.019","article-title":"Imaging of CA IX with fluorescent labelled sulfonamides distinguishes hypoxic and (re)-oxygenated cells in a xenograft tumour model","volume":"92","author":"Dubois","year":"2009","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib46","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/cddis.2012.181","article-title":"Targeting ATR in\u00a0vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation","volume":"3","author":"Fokas","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2016.10.037_bib47","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1158\/0008-5472.CAN-13-3369","article-title":"ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responses","volume":"74","author":"Josse","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib48","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.18632\/oncotarget.2158","article-title":"Potentiation of tumor responses to DNA damaging therapy by the selective ATR inhibitor VX-970","volume":"5","author":"Hall","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2016.10.037_bib49","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib50","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/00016925709170930","article-title":"The influence of oxygen on the radiosensitivity of mammalian tissues","volume":"48","author":"Wright","year":"1957","journal-title":"Acta radiol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib51","first-page":"199","article-title":"Knock-down of hypoxia-induced carbonic anhydrases IX and XII radiosensitizes tumor cells by increasing intracellular acidosis","volume":"2","author":"Doyen","year":"2012","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2016.10.037_bib52","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.molonc.2016.01.003","article-title":"Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells","volume":"10","author":"Kulshrestha","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib53","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2217\/14796694.1.6.779","article-title":"Tumor acidity, chemoresistance and proton pump inhibitors","volume":"1","author":"De Milito","year":"2005","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/mol.106.030494","article-title":"Genomic screening in\u00a0vivo reveals the role played by vacuolar H+ ATPase and cytosolic acidification in sensitivity to DNA-damaging agents such as cisplatin","volume":"71","author":"Liao","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mrrev.2015.01.001","article-title":"How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models","volume":"764","author":"van Gisbergen","year":"2015","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"key":"10.1016\/j.ejmech.2016.10.037_bib56","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1172\/JCI67232","article-title":"Potential applications for biguanides in oncology","volume":"123","author":"Pollak","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ejmech.2016.10.037_bib57","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ejmech.2016.10.037_bib58","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Phenformin induces cell cycle change, apoptosis, and mesenchymal-epithelial transition and regulates the AMPK\/mTOR\/p70s6k and MAPK\/ERK pathways in breast Cancer cells","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2016.10.037_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2012.12.008","article-title":"LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin","volume":"23","author":"Shackelford","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2016.10.037_bib60","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1002\/anie.201310709","article-title":"A\u00a0small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors","volume":"53","author":"Krall","year":"2014","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2016.10.037_bib61","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2016.10.037_bib62","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-11-1877","article-title":"Carbonic anhydrase IX promotes tumor growth and necrosis in\u00a0vivo and inhibition enhances anti-VEGF therapy","volume":"18","author":"McIntyre","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416308996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T19:40:10Z","timestamp":1657482010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416308996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":62,"alternative-id":["S0223523416308996"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.037","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.10.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}